Home
About
Services
Partners
Client Portfolio
News
Contact
Former CEO of shut Philadelphia refinery seeks to buy the plant
August 28, 2019
Explainer: U.S. dollar intervention: What would it take?
August 28, 2019
0
U.S. judge rules for Regeneron, Sanofi in Amgen cholesterol drug patent fight
Published by
Muller&Green
at
August 28, 2019
Categories
RSS
Tags
A U.S. judge on Wednesday set aside a jury verdict that found Amgen Inc patents on its cholesterol drug Repatha were valid, handing a victory to Regeneron Pharmaceuticals Inc and Sanofi SA , which sells a rival drug.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more